MPI Research, InviCRO, and 3D Imaging have joined forces to open a new 10,000-sq-ft translational imaging center in Michigan.
The partnership offers key translational equipment and expertise to generate the images and data required for the development of new radioisotopes, the companies said.
MPI Research is providing contract research services, while InviCRO brings imaging services and software to the table. For its part, 3D Imaging operates the center's cyclotron, which offers scientists new opportunities to accelerate drug development through the use of molecular imaging radioisotopes to track the distribution and efficacy of drug candidates, according to the companies. Enhanced precision and targeting of agents offers the potential to reduce the number of trials needed to bring a drug to market, minimizing cost and time.
The three firms broke ground on the project last September, with the cyclotron arriving in February of this year, they said. The center is housed on the grounds of MPI Research in Mattawan, MI, and its services are now commercially available to the drug development community.
